We report a 25-year-old woman presenting with sarcoidosis and bilateral sacroiliitis. Her sarcoidosis related symptoms (malaise, cough and dyspnoea) improved dramatically under treatment with steroids but severe back pain persisted. Only seven similar cases have been described over the last 40 years and the question of a possible association between the two diseases has been raised. However, prevalence data from the literature and the apparent lack of genetic links are better arguments for coincidence than for association.
INTRODUCTION
Since 1951, when Verstraeten (1) reported a first case with both sacroiliitis and sarcoidosis, six similar cases have been described in the literature, including only one female patient. Already Verstraeten and later Martin (2), Deshayes (3), Cabanel (4), Blanchon (5) and Gerster (6) raised the question about a possible association between the two diseases. We report another case of a 25-year-old woman presenting typical findings of sarcoidosis and a six-month history of bilateral iliosacral pain. The probability of an association between the two diseases is discussed.
CASE REPORT
The personal history of the 25-year-old female patient revealed a single episode of lumbar pain on motion irradiating to both legs in 1985; X-rays showed a spondylolisthesis of L5 on S1. Being in good health until February 1990, the patient then noted pain in her midback and in the area of the right sacroiliac joint irradiating to the right buttock. Maximum pain regularly interrupted her sleep between one and three o'clock in the Department of Rheumatology and Physical Therapy, *Department of Internal Medicine, University Hospital, Zurich, Switzerland. morning. And low back stiffness was present for about two hours after rising. Further symptoms included recurrent fever up to 38~ poor appetite, and weight loss of 10 kilos within a six-month period. In March 1990 ankylosing spondylitis was diagnosed by a practicing rheumatologist based on symptoms, clinical findings and inflammatory erosive X-ray changes of both sacroiliac joints (Fig. 1) . HLA-B27 was positive, an ileocolonoscopy including biopsy and histology examinations of both the ileum and colon were normal, the erythrocyte sedimentation rate (ESR) was 16 mm after 1 hour (Westergren). There was no evidence of presence of another form among the seronegative spondyloarthropathies. In June 1990 the patient was referred to our inpatient clinic for evaluation because of severe general malaise and increasing pain resistent to NSAID's (indomethacin, diclofenac, ibuprofen, phenylbutazone). Upon admission the patient reported severe low back pain irradiating to the buttocks, dyspnoea and palpitation when climbing two flights of stairs, and a nonproductive cough. The clinical examination revealed limited painful motion of both lumbar (Schober Index 10/11 cm) and thoracic spine in all directions. The thoracic excursion was limited to 80/83 cm. The sacroiliac provocation tests were strongly positive on both sides. No other significant findings were present. Laboratory screening showed an ESR of 34 mm after 1 hour, a C-reactive protein of 36.1 mg/1 (upper limit 10 mg/1), a slight thrombocytosis of 443 x 103/~tl and normocalcaemia (the reported incidence of hypercalcaemia in sarcoidosis varies from 2 to 63%, (7)). The angiotensin converting enzyme level was also within normal limits (44% of patients with bihilar lymphadenopathy but normal lung parenchyma have angiotensin converting enzyme levels within normal limits, (8)). On chest X-ray (Fig. 2) a bihilar lymphadenopathy and a normal lung parenchyma were found and confirmed by computerized tomography. Pulmonary function tests revealed a moderate restrictive lung disease with a mild obstructive component, and a slightly decreased carbon monoxide diffusing capacity. Transbronchial biopsy showed multiple noncaseating granulomas with epitheloid and multinucleated giant cells (Fig. 3) , and bronchioalveolar lavage yielded an increased helper T-cell to supressor T-cell ratio of 4.5:1 (a ratio of over 3.5:1 yielded a sensitivity of 53.2% and a specificity of 92.8% in accord with reference 9). The ratio in the blood was 2.1:1. All acid-fast and fungal stains and cultures were negative. Electrocardiogram, echocardiography, and ophthalmologic examination were normal. Under treatment with prednisone starting at 50 mg per day, general malaise, dyspnoea and cough disappeared, and ESR (6 mm/1 hour), C-reactive protein (16 rag/l), pulmonary function tests and bihilar lymphadenopathy returned to normal. After a follow-up of one year, however, the patient still suffers from severe low back pain exacerbating at night despite high doses of indomethacin. A tissue typing for the HLA antigens revealed the following resuits: A1, -; B8, 27; DR3, 4 (DRw52, 53; DQw2, 3).
DISCUSSION

Fig. 2:
Chest roentgenogram showing bilateral hilar lymphadenopathy. This is a report of a 25-year-old woman with ankylosing spondylitis who developed symptomatic pulmonary sarcoidosis. Despite prompt improvement of the sarcoidosis related malaise, dyspnoea and cough as well as the ESR under treatment with prednisone, persistent in- flammatory back pain was noted despite additional NSAID therapy. This difference between the therapeutic responses of pulmonary and musculoskeletal symptoms suggests the presence of different pathogenetic mechanisms involved in the two disorders. Based on epidemiological data there is no reason to assume an association of the two entities each having a relatively high prevalence. The prevalence of ankylosing spondylitis is reported as 1 per 1000 population (10) , and the prevalence of sarcoidosis varies from 0.04 in Spain to 64 per 1000 population in Sweden (11) . Therefore, based on pure coincidence, prevalence data for the two disorders are to be expected in the order of 0.00004 to 0.064 per 1000, the numbers being even higher if association of the two diseases is assumed. In the literature, however, only seven similar cases were reported over a period of 39 years indicating the lack of an association between sarcoidosis and ankylosing spondylitis ((1-6,12), Table I ). A genetically-determined predisposition to develop either sarcoidosis or ankylosing spondylitis has been noted in certain groups of patients. HLA-DR5 was significantly increased in an endemic cluster of patients with sarcoidosis in Germany (13, 14) , and HLA-B8 has been associated with acute sarcoidosis -related arthritis (15) and with spontaneous resolution (16) . HLA-B8 and HLA-DR3 have been associated with acute onset of sarcoidosis with arthritis (17, 18) . On the other hand, there is a clear association of ankylosing spondylitis with HLA-B27 (19) . However, no common genetic links have been identified for the two disorders. Interestingly, in our patient we found HLA-B27 as well as HLA-B8 and HLA-DR3 to be positive. The presence of the typical HLA specificities for both diseases may indicate the coexistence of two independent disease processes.
In conclusion, response to therapy, prevalence data from the literature and the apparent lack of genetic links are better arguments for coincidence than for association.
